Fever News and Research

RSS

Study investigates effect of paracetamol during pregnancy on child development

Paracetamol (acetaminophen) is the most commonly used medicine in pregnancy, yet there are very few studies that have investigated the possible long-term consequences for the child. A new study from the Norwegian Institute of Public Health suggests that long-term use of paracetamol during pregnancy may increase the risk of adverse effects on child development.

29 Oct 2013

Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

New findings from two integrated Phase 3 Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with STELARA- (ustekinumab) resulted in significantly greater inhibition of structural damage in patients with active psoriatic arthritis compared with placebo.

29 Oct 2013

Republicans eye health law opportunities to make midterm inroads

Republicans are set to pounce on the health law's rollout problems as a way to make inroads in 2014's midterm elections. Among the strategies they are considering is leaving the law out of budget negotiations but voting again in the House to delay the law.

29 Oct 2013

Researchers identify risk factors, protective medication for people living with lupus

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

28 Oct 2013

First Edition: October 28, 2013

Today's headlines include coverage of the health law's federal online insurance marketplace -- healthcare.gov -- and its continuing challenges, troubles and the plans to get it fixed.

28 Oct 2013

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Medicaid beneficiaries with lupus are not adequately following their treatment plans, and this puts them at risk for poor health outcomes, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. For most lupus medications, fewer than one in three beneficiaries were found to be adherent.

28 Oct 2013

Apremilast drug shows promise for Behcet's ulcers

Apremilast, an orally available small molecule modulating several inflammatory pathways, which is pending approval by the United States Food and Drug Administration, is showing promise in the treatment of mouth and genital ulcers in people with Behcet's syndrome, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Diego.

28 Oct 2013

Children born to mothers with lupus have twice the risk of autism spectrum disorders

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, children born to mothers with lupus may be at twice the risk of autism spectrum disorders than those born to mothers without the disease.

28 Oct 2013

Elderly people at increased risk for getting flu

Flu season lurks around the corner throughout the United States, and gerontologists at the University of Alabama at Birmingham say the elderly are at increased risk for getting the flu and often have a worse time coping with flu symptoms than do younger people.

24 Oct 2013

Rethinking the 1930s attack on malaria may help solve modern day malaria outbreaks

A new University of Texas at Arlington study about the elimination of malaria in the 1930s American South may have significant implications for solving modern day malaria outbreaks in parts of Africa, Central and Latin America, and Asia.

24 Oct 2013

BCG asthma effects are lost in adolescence

Any beneficial effects of the neonatal Bacillus Calmette–Guérin vaccine on childhood asthma symptoms and outcomes are likely to be transient, disappearing by adolescence, show follow-up findings from the Manchester Community Asthma Study.

23 Oct 2013

New flu vaccine offers better protection against circulating flu viruses

Last year's flu season was considered one of the strongest and deadliest in recent decades, according to the CDC. In preparation for this year's flu season, Concentra, a subsidiary of Humana Inc., offers a flu vaccine to provide greater protection against circulating flu strains.

23 Oct 2013

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

NanoViricides, Inc. (the "Company") reports that its optimized injectable FluCide® drug candidate was found to be well tolerated in a non-GLP small animal safety/toxicology study. This study is an important step in the drug development pathway for FluCide.

21 Oct 2013

Phase 2b study of JAK3 inhibitor VX-509 shows improvement in people with active RA

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced 12-week results from an ongoing Phase 2b study of VX-509, an investigational oral, selective Janus kinase 3 (JAK3) inhibitor, dosed once or twice daily in people with active rheumatoid arthritis (RA) taking methotrexate

19 Oct 2013

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.

18 Oct 2013

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Pfizer Inc. (NYSE:PFE) announced today that the European Commission approved updates to the Summary of Product Characteristics (SmPC) for the company's pneumococcal conjugate vaccine Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), regarding its use in certain populations at high risk of pneumococcal disease.

18 Oct 2013

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.

17 Oct 2013

Measles-containing vaccines administered at 12-5 months of age associated with reduced risk of fever, seizures

Children receiving measles-containing vaccines at 12-15 months of age have a lower increased risk of fever and seizures than those who receive them at 16-23 months of age, according to a new Kaiser Permanente study published in JAMA Pediatrics.

15 Oct 2013

Research finding may help patients to better survive severe infectious diseases

Scientists of Charité - Universitätsmedizin Berlin for the first time have solved the 3-dimensional structure of the protein LBP and it´s genetic variant. This finding may help certain patients to better survive severe infectious diseases. The results have been published in the recent issue of the journal Immunity.

15 Oct 2013

Study shows IBD patients may have increased risk of heart attack, stroke

Patients with inflammatory bowel disease are at an increased risk of stroke and heart attack according to a new study presented by Mayo Clinic researchers at the American College of Gastroenterology's Annual Scientific Meeting, Oct. 11-16, in San Diego.

15 Oct 2013

Fever News and Research

Study investigates effect of paracetamol during pregnancy on child development

Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

Republicans eye health law opportunities to make midterm inroads

Researchers identify risk factors, protective medication for people living with lupus

First Edition: October 28, 2013

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Apremilast drug shows promise for Behcet's ulcers

Children born to mothers with lupus have twice the risk of autism spectrum disorders

Elderly people at increased risk for getting flu

Rethinking the 1930s attack on malaria may help solve modern day malaria outbreaks

BCG asthma effects are lost in adolescence

New flu vaccine offers better protection against circulating flu viruses

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

Phase 2b study of JAK3 inhibitor VX-509 shows improvement in people with active RA

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Measles-containing vaccines administered at 12-5 months of age associated with reduced risk of fever, seizures

Research finding may help patients to better survive severe infectious diseases

Study shows IBD patients may have increased risk of heart attack, stroke

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News